Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Isambert

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
ESMO Open|September 15, 2022
Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumorsC Le Tourneau, H Becker, R Claus, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 24, 2017
Patterns of care and clinical outcomes in primary oesophageal gastrointestinal stromal tumours (GIST): A retrospective study of the French Sarcoma Group (FSG)F Duffaud, P Meeus, F Bertucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2013
Advanced soft-tissue sarcoma in elderly patients: patterns of care and survivalD Garbay, R G Maki, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2013
Correlation between overall survival and growth modulation index in pre-treated sarcoma patients: a study from the French Sarcoma GroupS Cousin, J Y Blay, F Bertucci, et al.
British Journal of Cancer|January 14, 2012
Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2E Brain, N Isambert, F Dalenc, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 19, 2018
European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Experience with Advanced/Metastatic Epithelioid Sarcoma Patients Treated in Prospective Trials: Clinical Profile and Response to Systemic TherapyN Touati, P Schöffski, S Litière, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2011
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcomeN Penel, A Italiano, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2011
Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG)D Garbay, A Le Cesne, N Penel, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2015
A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trialB Bui-Nguyen, J E Butrynski, N Penel, et al.
Acta Gastro-Enterologica Belgica|March 22, 2018
Patients with primary localized high-grade sarcomas of the digestive tract excluding GIST : a retrospective study from the French sarcoma groupA de Nonneville, C Toullec, J Y Blay, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
ESMO Open|September 15, 2022
Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumorsC Le Tourneau, H Becker, R Claus, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 24, 2017
Patterns of care and clinical outcomes in primary oesophageal gastrointestinal stromal tumours (GIST): A retrospective study of the French Sarcoma Group (FSG)F Duffaud, P Meeus, F Bertucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2013
Advanced soft-tissue sarcoma in elderly patients: patterns of care and survivalD Garbay, R G Maki, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2013
Correlation between overall survival and growth modulation index in pre-treated sarcoma patients: a study from the French Sarcoma GroupS Cousin, J Y Blay, F Bertucci, et al.
British Journal of Cancer|January 14, 2012
Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2E Brain, N Isambert, F Dalenc, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 19, 2018
European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Experience with Advanced/Metastatic Epithelioid Sarcoma Patients Treated in Prospective Trials: Clinical Profile and Response to Systemic TherapyN Touati, P Schöffski, S Litière, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2011
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcomeN Penel, A Italiano, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2011
Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG)D Garbay, A Le Cesne, N Penel, et al.
European Journal of Cancer (Oxford, England : 1990)|April 28, 2015
A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trialB Bui-Nguyen, J E Butrynski, N Penel, et al.
Acta Gastro-Enterologica Belgica|March 22, 2018
Patients with primary localized high-grade sarcomas of the digestive tract excluding GIST : a retrospective study from the French sarcoma groupA de Nonneville, C Toullec, J Y Blay, et al.
Pageof 6